Despite highest-ever quarterly revenues, Aurobindo Q3 net profit falls 10%
HYDERABAD: Degrowth in its US formulations business dragged down Aurobindo Pharma’s consolidated net profits for the third quarter ended December...
HYDERABAD: Degrowth in its US formulations business dragged down Aurobindo Pharma’s consolidated net profits for the third quarter ended December...